Skip to main content

AL Sydbank A/S share buyback programme: transactions in week 22

        Company Announcement No 27/2026Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37 AL Sydbank A/SCVR No DK 12626509, Aabenraaal-sydbank.com1 June 2026  Dear Sirs AL Sydbank A/S share buyback programme: transactions in week 22On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027. The purpose of the share buyback programme is to reduce the share capital of AL Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the...

Continue reading

Exploration Expands the High–Grade Silver-Lead Cate-8 Vein Discovered in the Upper Area of the Mine

KELLOGG, Idaho and VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) reports further successful results from the ongoing exploration drill program testing the high-grade silver-lead Cate-8 Vein discovery adjacent to current development in the upper area of the Bunker Hill mine (the “Bunker Hill Mine”). Seven holes have been drilled to date for a total of 2,750 feet from the 8 Level. Assay results for the first five drillholes show significant intercepts, summarized below (results for BHE26-01 and BHE26-02 reported in the Company’s press releases dated May 4, 2026 and May 12, 2026). The last two drill holes, BHE26-06 and BHE26-07, also both intersected siderite-galena veins ranging from 1 to 6 feet in length; these holes have been logged, and...

Continue reading

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask (“Regenixé Mask”), a beauty product developed by Chemokine Pte Ltd (“Chemokine”). EUDA holds the exclusive global distributorship rights for Helixé products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on molecular supplements and gene-modulating formulations. Regenixé Mask is formulated with iPSC-derived skin stem cell secretome technology and cellulose mask technology designed to support...

Continue reading

ASUS Republic of Gamers Unveils ROG G1000 Edition 20 Desktop and ROG Xbox Ally X20 Bundle at Computex 2026

Two new anniversary flagships lead ROG’s Computex showcase, joined by the new Strix SCAR 18 and the latest evolution of ROG Nebula HDR Displays KEY POINTSROG Edition 20 debuts: ROG celebrates 20 years of gaming innovation with a limited anniversary collection spanning desktop, handheld, laptop, and more Two anniversary flagships: ROG G1000 Edition 20 introduces a limited-edition flagship desktop, while the ROG Xbox Ally X20 Bundle pairs the anniversary handheld with exclusive ROG XREAL R1 Edition 20 Gaming AR Glasses Flagship laptop performance: The 2026 ROG Strix SCAR 18 brings the latest ROG Nebula HDR, Extreme Low Motion Blur, and up to RTX 5090 Laptop GPUTORONTO, June 01, 2026 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) today introduced two new flagships at Computex 2026: the ROG G1000 Edition 20, a limited-edition...

Continue reading

Himax Latest T2000 Tcon to Power the Evolution of E Ink Next-Generation Color ePaper into Dynamic Content Applications

TAINAN, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that its new T2000 Color ePaper Timing Controller (Color ePaper Tcon) has been successfully adopted into the latest ePaper controller architecture launched by E Ink, the global leader in ePaper technology. For large-format color ePaper signage, the T2000 Tcon delivers significantly enhanced dynamic content display performance, enabling support for dynamic advertising content and accelerating the transition from traditional static displays to a new generation of dynamic applications. The T2000 Tcon is now powering E Ink’s 75-inch Kaleido™ large-format color ePaper signage platform, which will be...

Continue reading

EfTEN Real Estate Fund AS acquired the Magistral shopping center

EfTEN Real Estate Fund AS acquired the Magistral shopping center from EfTEN Kinnisvarafond II AS. In connection with the expiration of the term of EfTEN Kinnisvarafond II AS, EfTEN Kinnisvarafond II AS sold the 100% holding in Magistral Kaubanduskeskuse OÜ to EfTEN Real Estate Fund AS. The acquisition of the asset from another fund managed by the same fund manager was carried out in accordance with the conditions set out in the Investment Funds Act, and the fund’s shareholders had previously granted the management board the corresponding authorisations at the general meeting held on 07.04.2026. The basis for determining the fair value of the sale price of the company’s holding was the value of the real estate owned by the company at €31,690,000, as valued as of the end of May by Colliers International Advisors OÜ. The sale...

Continue reading

Form 8.3 – [NCC GROUP PLC – 29 05 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree NCC GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 29 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 28 05 2026] – (CGWL) – CORRECTION RE PURCHASE AND SALE DETAIL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Geopolitical and AI-related risks among top concerns for directors and officers worldwide, according to Willis

LONDON, June 01, 2026 (GLOBE NEWSWIRE) — 59% of directors and officers now consider geopolitical risks to be very important or extremely important to their organisation, according to the latest Directors and officers liability insurance survey by Willis, a WTW business, (NASDAQ:WTW), conducted in collaboration with international law firm, Reed Smith LLP. Geopolitical risks in particular has hit the top 7 global risks for directors and officers in a marked change from last year where it was only ranked 15th (out of 30 risks canvassed). Artificial intelligence has seen a significant increase in the proportion of respondents ranking it as a very or extremely important risk (up 5% to 56% of respondents globally). This is particularly prevalent in North America, with 71% of respondents citing is as a very or extremely important risk...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.